Unknown

Dataset Information

0

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.


ABSTRACT: BACKGROUND:Diffuse large B-cell lymphomas (DLBCLs) are phenotypically and genetically heterogeneous. Gene-expression profiling has identified subgroups of DLBCL (activated B-cell-like [ABC], germinal-center B-cell-like [GCB], and unclassified) according to cell of origin that are associated with a differential response to chemotherapy and targeted agents. We sought to extend these findings by identifying genetic subtypes of DLBCL based on shared genomic abnormalities and to uncover therapeutic vulnerabilities based on tumor genetics. METHODS:We studied 574 DLBCL biopsy samples using exome and transcriptome sequencing, array-based DNA copy-number analysis, and targeted amplicon resequencing of 372 genes to identify genes with recurrent aberrations. We developed and implemented an algorithm to discover genetic subtypes based on the co-occurrence of genetic alterations. RESULTS:We identified four prominent genetic subtypes in DLBCL, termed MCD (based on the co-occurrence of MYD88L265P and CD79B mutations), BN2 (based on BCL6 fusions and NOTCH2 mutations), N1 (based on NOTCH1 mutations), and EZB (based on EZH2 mutations and BCL2 translocations). Genetic aberrations in multiple genes distinguished each genetic subtype from other DLBCLs. These subtypes differed phenotypically, as judged by differences in gene-expression signatures and responses to immunochemotherapy, with favorable survival in the BN2 and EZB subtypes and inferior outcomes in the MCD and N1 subtypes. Analysis of genetic pathways suggested that MCD and BN2 DLBCLs rely on "chronic active" B-cell receptor signaling that is amenable to therapeutic inhibition. CONCLUSIONS:We uncovered genetic subtypes of DLBCL with distinct genotypic, epigenetic, and clinical characteristics, providing a potential nosology for precision-medicine strategies in DLBCL. (Funded by the Intramural Research Program of the National Institutes of Health and others.).

SUBMITTER: Schmitz R 

PROVIDER: S-EPMC6010183 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

Schmitz Roland R   Wright George W GW   Huang Da Wei DW   Johnson Calvin A CA   Phelan James D JD   Wang James Q JQ   Roulland Sandrine S   Kasbekar Monica M   Young Ryan M RM   Shaffer Arthur L AL   Hodson Daniel J DJ   Xiao Wenming W   Yu Xin X   Yang Yandan Y   Zhao Hong H   Xu Weihong W   Liu Xuelu X   Zhou Bin B   Du Wei W   Chan Wing C WC   Jaffe Elaine S ES   Gascoyne Randy D RD   Connors Joseph M JM   Campo Elias E   Lopez-Guillermo Armando A   Rosenwald Andreas A   Ott German G   Delabie Jan J   Rimsza Lisa M LM   Tay Kuang Wei Kevin K   Zelenetz Andrew D AD   Leonard John P JP   Bartlett Nancy L NL   Tran Bao B   Shetty Jyoti J   Zhao Yongmei Y   Soppet Dan R DR   Pittaluga Stefania S   Wilson Wyndham H WH   Staudt Louis M LM  

The New England journal of medicine 20180401 15


<h4>Background</h4>Diffuse large B-cell lymphomas (DLBCLs) are phenotypically and genetically heterogeneous. Gene-expression profiling has identified subgroups of DLBCL (activated B-cell-like [ABC], germinal-center B-cell-like [GCB], and unclassified) according to cell of origin that are associated with a differential response to chemotherapy and targeted agents. We sought to extend these findings by identifying genetic subtypes of DLBCL based on shared genomic abnormalities and to uncover thera  ...[more]

Similar Datasets

| S-EPMC3387165 | biostudies-literature
| S-EPMC8377611 | biostudies-literature
| S-EPMC3816210 | biostudies-other
| S-EPMC7760867 | biostudies-literature
| S-EPMC3508519 | biostudies-literature
| S-EPMC6144206 | biostudies-literature
2002-06-27 | E-GEOD-60 | biostudies-arrayexpress
2002-06-27 | GSE60 | GEO
2021-11-04 | PXD028267 | Pride
| S-EPMC4017261 | biostudies-literature